Sage Journals: Discover world-class research

Free access

Brief report

First published 2018-5

Increased plasma FGF21 level as an early biomarker for insulin resistance and metabolic disturbance in obese insulin-resistant rats

Pongpan Tanajak, Wanpitak Pongkan, Siriporn C Chattipakorn [...]

Diabetes & Vascular Disease Research

Open access

Research article

First published 2019-10

Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension

Habib Bouzina, Roger Hesselstrand, Göran Rådegran

Pulmonary Circulation

Retricted access

Research article

First published 2016-03

Effect of Metformin on Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes

Hui Fan, XiaoMeng Sun, Heng Zhang [...]

Diabetes Technology & Therapeutics

Free access

Research article

First published 2017-11

The alterations of serum FGF-21 levels,metabolic and body composition in early breast cancer patients receiving adjuvant endocrine therapy

Murat Akyol, Ahmet Alacacioglu, Leyla Demir [...]

Cancer Biomarkers

Retricted access

Research article

First published 2022-11

Growth Differentiation Factor 15: A Novel Growth Biomarker for Children With Congenital Heart Disease

Dane C Paneitz, Alice Zhou, Lisa Yanek [...]

World Journal for Pediatric and Congenital Heart Surgery

Free access

Research article

First published 2012-11

Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23,sclerostin,bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase

Dagmar-Christiane Fischer, Anne Mischek, Sabrina Wolf [...]

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Retricted access

News

First published 2021-06

Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?

Joan Carles Domingo, Begoña Cordobilla, Roser Ferrer [...]

Antioxidants & Redox Signaling

Search results

Increased plasma FGF21 level as an early biomarker for insulin resistance and metabolic disturbance in obese insulin-resistant rats

Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension

Effect of Metformin on Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes

The alterations of serum FGF-21 levels,metabolic and body composition in early breast cancer patients receiving adjuvant endocrine therapy

Growth Differentiation Factor 15: A Novel Growth Biomarker for Children With Congenital Heart Disease

Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23,sclerostin,bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase

Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?